Clinical trials
Phase 1 Peanut Hypersensitivity trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2014 | 3 |
| 2016 | 2 |
| 2017 | 2 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Recruiting | 2 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Suspended | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astellas Pharma Global Development, Inc. | 2 |
| COUR Pharmaceutical Development Company, Inc. | 2 |
| DBV Technologies | 2 |
| HAL Allergy | 2 |
| Allergy Therapeutics | 1 |
| Allertein Therapeutics, LLC | 1 |
| Alton Melton | 1 |
| Baylor College of Medicine | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peanut Hypersensitivity | 24 |
| Food Hypersensitivity | 10 |
| Hypersensitivity | 4 |
| Anaphylaxis | 3 |
| Hypersensitivity, Immediate | 3 |
| Nut Hypersensitivity | 2 |
| Asthma | 1 |
| Dermatitis, Atopic | 1 |
| Egg Hypersensitivity | 1 |
| Milk Hypersensitivity | 1 |
Trials
Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.